S16G (p.Ser16Gly) variant of GHR (Growth hormone receptor)

S16G (p.Ser16Gly) in GHR (Growth hormone receptor) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data and structural context.

S16G (p.Ser16Gly) variant details